← hubDrugs

3 sources

← All substances
🔗 MergedComparePsychonautWikiTripSitPharmacology

How the databases line up — = agree, partial, differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).

Show:
PsychonautWikiTripSitPharmacology
Classification
Class / category
Also known as
1B-LSD
1b
Safety
Addiction potentialnon-addictive with a low abuse potential
Toxicity
extremely low toxicity relative to dose
Dangerous interactions
Unsafe interactions
Dose · Oral
Threshold15 µg
Light25–75 µg25–50 µg
Common75–150 µg50–125 µg
Strong150–300 µg125–250 µg
Heavy300 µg+
Duration
Onset20–60 minutes45–90 minutes
Total8–12 hours8–12 hours=
After-effects6–24 hours6–24 hours=
Pharmacology

Dose at a glance

Each database's primary-route ladder on one shared scale — see where ranges line up or shift.

PsychonautWiki oral
TripSit Oral
0375 µg
LightCommonStrongHeavy

Duration at a glance

Total duration on one shared scale.

PsychonautWiki
8–12 hours
TripSit
8–12 hours

TripSit summary

1B-LSD (1-butanoyl-lysergic acid diethylamide) is an LSD analogue which appears to be about as potent as 1P-LSD (slightly more potent than LSD) and has a slightly shorter duration than that of LSD, again thought to be about the same as 1P-LSD. Released in late 2018, and marketed agressively as a replacement for 1P-LSD. 1B-LSD does not yet have a clearly established safety profile,

Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.